LOGIN
Mobile compression device vs. heparin for prevention of thromboembolic events after THA
August 2013
Mobile compression device vs. heparin for prevention of thromboembolic events after THA
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Thrombosis prevention after total hip arthroplasty: a prospective, randomized trial comparing a mobile compression device with low-molecular-weight heparin
J Bone Joint Surg Am. 2010 Mar;92(3):527-35Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
OE EXCLUSIVE
Dr. Colwell discusses his study assessing the safety of a mobile compression device for thrombo-prophylaxis.
Synopsis
386 patients (>18 yr) who had been scheduled for 389 total hip arthroplasties were randomized to receive thromboprophylaxis by either a mobile compression device (CECT SFT) or standardly accepted low-molecular-weight heparin (LMWH).The CECT SFT demonstrated effective thromboprophylaxis with a better safety profile (fewer major bleeding events) compared to LMWH.
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.